Supplementary Material AUTHOR CONTRIBUTIONS: J.A.M. conceived the idea, directed the project, and wrote the manuscript. E. C., J.G., S. V., and A. G. M. were involved in the design, development, and analysis of all the cell-based and enzymatic experiments, and analyzed the data. J. B-B. and B. M-C. provided intellectual insights and critically read the manuscript. J. L-S. and A. S-C. provided essential materials necessary for the study. A. N-C. and M. S-M. performed virtual profiling, docking and molecular dynamics-based calculations and scorings, and examined all the chemoinformatic data. A. L., S. C., and C. S. performed chemical synthesis and analytical characterization of oleacein mimetics. CONFLICTS OF INTEREST: Stock ownership: Á.G.M., StemTek Therapeutics (CEO). All other authors have no competing interests to declare. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Ethics approval was not required for this study as per the local legislation. FUNDING: Work in the Menendez laboratory is supported by the Spanish Ministry of Science and Innovation (Grants SAF2016-80639-P and PID2019-104055GB-I00, Plan Nacional de I+D+I, founded by the European Regional Development Fund, Spain) and by an unrestricted research grant from the Fundació Oncolliga Girona (Lliga catalana d’ajuda al malalt de càncer, Girona). Joaquim Bosch-Barrera is the recipient of research grants from La Marató de TV3 foundation (201906) and the Health Research and Innovation Strategic Plan (SLT006/17/114; PERIS 2016-2020; Pla stratègic de recerca i innovació en salut; Departament de Salut, Generalitat de Catalunya).